Merck launches corporate ad blitz

Share this article:
Merck launched its first corporate advertising campaign in its 114-year history over the weekend, telling consumers that it's "Where patients come first."
The campaign, by Ogilvy & Mather New York, includes 3 TV ads running on network and cable channels, along with print ads running in The New York Times, The Wall Street Journal and more than 40 magazines, including Time, Newsweek and Readers Digest. The ads target adults 40 and over, those most likely to be concerned with their own health and to be healthcare decision-makers for their own families. Forty percent of the buy is being allocated to ads touting Merck's patient assistance programs.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...